266 related articles for article (PubMed ID: 29185875)
1. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response.
Choi NW; Estes MK; Langridge WH
J Biotechnol; 2006 Jan; 121(2):272-83. PubMed ID: 16181698
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice.
Afchangi A; Jalilvand S; Arashkia A; Latifi T; Farahmand M; Abolghasem Shirazi MM; Mousavi Nasab SD; Marashi SM; Roohvand F; Shoja Z
Microb Pathog; 2022 Feb; 163():105405. PubMed ID: 35045328
[TBL] [Abstract][Full Text] [Related]
4. NSP4 antibody levels in rotavirus gastroenteritis patients with seizures.
Yeom JS; Kim YS; Jun JS; Do HJ; Park JS; Seo JH; Park ES; Lim JY; Woo HO; Park CH; Youn HS
Eur J Paediatr Neurol; 2017 Mar; 21(2):367-373. PubMed ID: 27847298
[TBL] [Abstract][Full Text] [Related]
5. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
6. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
Lappalainen S; Tamminen K; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
[TBL] [Abstract][Full Text] [Related]
8. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis.
Choi NW; Estes MK; Langridge WH
Vaccine; 2005 Oct; 23(44):5168-76. PubMed ID: 16040169
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T lymphocyte response against extrahepatic biliary epithelium is activated by epitopes within NSP4 in experimental biliary atresia.
Zheng S; Zhang H; Zhang X; Peng F; Chen X; Yang J; Brigstock D; Feng J
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G233-40. PubMed ID: 24875101
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7.
Xie L; Yan M; Wang X; Ye J; Mi K; Yan S; Niu X; Li H; Sun M
Virus Res; 2015 Dec; 210():298-307. PubMed ID: 26368053
[TBL] [Abstract][Full Text] [Related]
12. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
[TBL] [Abstract][Full Text] [Related]
13. Development of a Bacillus subtilis-based rotavirus vaccine.
Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
[TBL] [Abstract][Full Text] [Related]
14. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
Iosef C; Chang KO; Azevedo MS; Saif LJ
J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
[TBL] [Abstract][Full Text] [Related]
15. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus vaccination and infection induce VP6-specific IgA responses.
Lappalainen S; Blazevic V; Malm M; Vesikari T
J Med Virol; 2017 Feb; 89(2):239-245. PubMed ID: 27431308
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL
Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936
[TBL] [Abstract][Full Text] [Related]
18. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL
Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection.
Vizzi E; Calviño E; González R; Pérez-Schael I; Ciarlet M; Kang G; Estes MK; Liprandi F; Ludert JE
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1157-63. PubMed ID: 16210477
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
Malm M; Heinimäki S; Vesikari T; Blazevic V
Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
